Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Mass spectrometry imaging: How will it affect clinical research in the future?
Dilillo M, Heijs B, McDonnell LA. Dilillo M, et al. Expert Rev Proteomics. 2018 Sep;15(9):709-716. doi: 10.1080/14789450.2018.1521278. Epub 2018 Sep 19. Expert Rev Proteomics. 2018. PMID: 30203995 Review.
Mass spectrometry imaging (MSI) is a label free, multiplex imaging technology able to simultaneously record the distributions of 100's to 1000's of species, and which may be configured to study metabolites, lipids, glycans, peptides, and
Mass spectrometry imaging (MSI) is a label free, multiplex imaging technology able to simultaneously record the
Mass Spectrometry-based Biomarkers for Knee Osteoarthritis: A Systematic Review.
Haartmans MJJ, Emanuel KS, Tuijthof GJM, Heeren RMA, Emans PJ, Cillero-Pastor B. Haartmans MJJ, et al. Expert Rev Proteomics. 2021 Jul 6. doi: 10.1080/14789450.2021.1952868. Online ahead of print. Expert Rev Proteomics. 2021. PMID: 34228576
Specific biomarker profiles for early detection and guiding clinical decision-making of OA have not yet been identified. One technique that can contribute to the finding of this "OA biomarker" is mass spectrometry (MS), which offers the possibility to analyze …
Specific biomarker profiles for early detection and guiding clinical decision-making of OA have not yet been identified. One techniqu …